Liściokwiaty – egzotyczne rośliny lecznicze

1. Calixto JB, Santos ARS, Filho VC i wsp. A review of the plants of the genus Phyllanthus: Their chemistry, pharmacology, and therapeutic potential. Med Res Rev 1998; 18:225-58. 2. Żurowska K. Ziołolecznictwo amazońskie i andyjskie. Tower Press, Gdańsk 2001; 55. 3. Sparzak B, Krauze-Baranowska M, Pobłocka-Olech L. HPTLC determination of catechins in in vitro cultures of two species of the genus Phyllanthus. J Planar Chromatogr – Mod TLC 2008; 21:103-6. 4. Ihantola-Vormisto A, Summanen J, Kankaanranta H i wsp. Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 1997; 63:518-24. 5. Otto M, Thyagarajan SP, Gupta MB. Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer 1 and cellular transcription factors. Eur J Clin Invest 1997; 27:908-15. 6. http://www.wzwb.pl/. 7. Polański J. Hepatologia – kompendium, Medical Tribune Group, Warszawa 2004. 8. Venkateswaran PS, Millman I, Blumberg BS. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: In vitro and in vivo studies. Proc Nat Acad Sci USA 1987; 84:274-8. 9. Antonucci TK, Rutter WJ. Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner. J Virol 1989; 6:579-83. 10. Su H, Yee JK. Regulation of hepatitis B virus gene expression by its two enhancers. Proc Nat Acad Sci USA 1992; 92:2708-12. 11. Ishikawa T, Ganem D. The pre-S domain of the large viral envelope protein detennines host rang in avian hepatitis B viruses. Proc Nat Acad Sci USA 1995; 92:6259-63. 12. Argona E, Burk RD, Ott M i wsp. Cell-type specific mechanisms regulate hepatitis B virus transgene expression in liver and other organs. J Path 1996; 180:441-9. 13. Nakabayashi H, Taketa K, Miyano M i wsp. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Canc Res 1982; 42:3858-63. 14. Huang RL, Huang YL, Ou JC i wsp. Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro. Phyt Res 2003; 17:449-53. 15. Blumberg BS, Millman I, Yenkateswaran PS i wsp. Hepatitis B virus and hepatocellular carcinoma – treatment of HBV carriers with Phyllanthus amarus. Canc Detect Prev 1989; 14:195-201. 16. Thyagarajan SP, Subramanian S, Thirunalasundari T i wsp. Effect of Phylanthus amarus on chronic carriers of hepatitis B virus. Lancet 1988; 2:764-6. 17. Yeh SF, Hong CY, Huang YL i wsp. Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells. Antiviral Res 1993; 20:185-92. 18. Chan HLY, Sung JJY, Fong WF i wsp. Double-blinded placebo-controlled study of Phyllanthus urinaria for treatment of chronic hepatitis B. Alim Pharm Therap 2003; 18:339-45. 19. Liu J, Lin H, McIntosh H. Genus Phyllanthus for chronic hepatitis B virus infection: A systematic review. J Viral Hepat 2001; 8:358-66. 20. www.aids.gov.pl. 21. De Clecq E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection, Med Res Rev 2000; 20:323-49. 22. Qian-Cutrone J, Huang S, Trimble J i wsp. Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri. J Nat Prod 1996; 59:196-9. 23. Naik AD, Juvekar AR. Effects of alkaloidal extract of Phyllanthus niruri on HIV replication. Indian J Med Sci 2003; 57:387-93. 24. Wang CY, Sun S-W, Lee S-S. Pharmacokinetic and metabolic studies of retrojusticidin B, a potential anti-viral lignan, in rats. Planta Med 2004; 70:1161-5. 25. Notka F, Meier G, Wagner R. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antivir Res 2004; 64:93-102. 26. Wright CI, Van-Buren L, Kroner CI i wsp. Herbal medicines as diuretics: A review of the scientific evidence. J Ethnopharm 2007; 114:1-31. 27. Antczak A. Kamica górnego odcinka układu moczowego. Przew Lek 2001; 4:10,89-92. 28. Nishiura JL, Campos AH, Boim MA. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urol Res 2004; 32:362-6. 29. Gürocak S, Küpeli B. Consumption of historical and current phytotherapeutic agents for urolithiasis: A critical review. J Urol 2006; 176:450-5. 30. Micali S, Sighinolfi MC, Celia A i wsp. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol 2006; 176:1020-2. 31. Paulino N, Filho VC, Yunes RA i wsp. The relaxant effect of extract of Phyllanthus urinaria in the guinea-pig isolated trachea. Evidence for involvement of ATP-sensitive potassium channels. J Pharm Pharmacol 1996; 48:1158-63. 32. Dias MA, Campos AH, Filho VC i wsp. Analysis of the mechanisms underlying the contractile response induced by the hydroalcoholic extract of Phyllanthus urinaria in the guinea-pig urinary bladder in vitro. J Pharm Pharmacol 1995; 47:846-51. 33. Gorski F, Correa CR, Filho VC i wsp. Potent antinociceptive activity of a hydroalcoholic extract of Phyllanthus corcovadensis. J Pharm Pharmacol 1993; 45:1046-9. 34. Santos ARS, Filho VC, Yunes RA i wsp. Analysis of the mechanisms underlying the antinociceptive effect of the extracts of plants from the genus Phyllanthus. Gen Pharmacol 1995; 26:1499-506. 35. Catapan E, Otuki MF, Viana AM i wsp. Pharmacological activity and chemical composition of callus culture extracts from selected species of Phyllanthus. Pharmazie 2000; 55:945-6. 36. Tchórzewski H. Zapalenie: patofizjologia i klinika. Wyd Med Medpress, Warszawa 1998. 37. Kiemer AK, Hartung T, Huber C i wsp. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kB pathway. J Hepat 2003; 38:289-97. 38. Bourdi M, Masubuchi Y, Reilly TP i wsp. Protection against acetaminophen-induced liver injury and lethality by IL-10: role of inducible nitric oxide synthase. Hepatology 2002; 35:289-98. 39. Kato M, Ikeda N, Matsushita E i wsp. Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by concanvalin. Hepat Res 2001; 20:232-43. 40. Kumaran A, Karunakaran RJ. In vitro antioxidant activities of methanol extracts of five Phyllanthus species from India. LWT – Food Sci Technol 2007; 40:344-52. 41. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991; 65:1097-8. 42. Huang ST, Yang RC, Pang JHS. Aqueous extract of Phyllanthus urinaria induced apoptosis in human cancer cells. J Chin Med 2004; 32:175-83. 43. Sripanidkulchai B, Tattawasart U, Laupatarakasem P i wsp. Antimutagenic and anticarcinogenic effects of Phyllanthus amarus. Phytomedicine 2002; 9:26-32. 44. Mensah JL, Lagarde I, Ceschin C i wsp. Antibacterial activity of the leaves of Phyllanthus discoideus. J Ethnopharm 1990; 28:129-33. 45. Mazumder A, Mahato A, Mazumder R. Antimicrobial potentiality of Phyllanthus amarus against drug resistant pathogens. Nat Prod Res 2006; 20:323-6. 46. Ramesh N, Viswanathan MB, Tamil S i wsp. Antimicrobal and phythochemical studies on leaves of Phyllanthus singampattiana (Sebastine and A.N. Henry) kumari and chandrabose from India. Med Chem Res 2004; 13:348-60. 47. Olliaro PL, Yuthavog Y. An overview of chemotherapeutic targets for antimalaria drug discovery. Pharm Therap 1999; 81:91-110. 48. Tona L, Cimanga RK, Mesia K i wsp. In vitro antiplasmoidal activity of extracts and fractions from seven medical plants used in the Democratic Republic of Congo. J Ethnopharm 2003; 93:27-32. 49. Cimanga RK, Tona L, Luyindula N i wsp. In vitro antiplasmodial activity of callus culture extracts and fractions from fresh apical stems of Phyllanthus niruri L. ( Euphorbiaceae). Part 2. J Ethnopharm 2004; 95:399-404. 50. Luyindula N, Tona L, Lunkebila S i wsp. In vitro antiplasmodial activity of callus culture extracts from fresh apical stems of Phyllanthus niruri. Part 1. Pharm Biol 2004; 42:512-8.